5,6-Bis(1-phenylbenzimidazol-2-yl)pyrazine-2,3-diamine

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 苯并咪唑类
• 英文名称: 5,6-Bis(1-phenylbenzimidazol-2-yl)pyrazine-2,3-diamine
• 英文别名: 5,6-bis(1-phenylbenzimidazol-2-yl)pyrazine-2,3-diamine
• 化学式: C₃₀H₂₂N₈
• 分子量: 494.5
• InChiKey: GZSRKKZHGRCQSR-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  4.8
• 重原子数：
  38
• 可旋转键数：
  4
• 环数：
  7.0
• sp3杂化的碳原子比例：
  0.0
• 拓扑面积：
  114
• 氢给体数：
  2
• 氢受体数：
  6

文献信息

• HETEROCYCLIC COMPOUNDS AS ADENOSINE ANTAGONISTS
  申请人：GiraFpharma LLC

  公开号：US20190023666A1

  公开（公告）日：2019-01-24

  Aminopyrazine compounds as modulators of an adenosine receptor are provided. The compounds may find use as therapeutic agents for the treatment of diseases mediated through a G-protein-coupled receptor signaling pathway and may find particular use in oncology.

  提供了氨基吡嗪化合物作为腺苷受体的调节剂。这些化合物可能作为治疗经由G蛋白偶联受体信号通路介导的疾病的治疗剂，并且可能在肿瘤学中发挥特定作用。
• Heterocyclic compounds as adenosine antagonists
  申请人：NUVATION BIO INC.

  公开号：US11028058B2

  公开（公告）日：2021-06-08

  Aminopyrazine compounds as modulators of an adenosine receptor are provided. The compounds may find use as therapeutic agents for the treatment of diseases mediated through a G-protein-coupled receptor signaling pathway and may find particular use in oncology.

  提供了作为腺苷受体调节剂的氨基吡嗪化合物。这些化合物可用作治疗剂，用于治疗通过 G 蛋白偶联受体信号通路介导的疾病，尤其可用于肿瘤学。
• ORGANIC ELECTRONIC DEVICE
  申请人：Novaled GmbH

  公开号：EP2718978B1

  公开（公告）日：2018-05-16
• Compound for Organic Electronic Device
  申请人：Fadhel Omrane

  公开号：US20140174537A1

  公开（公告）日：2014-06-26

  The present invention relates to new naphthalene carbodiimide (NTCDI) derivatives, and organic electronic device using the same and especially to an organic solar cell. The new NTCDI derivatives are used as acceptor, electron transport material, and doped electron transport materials.
• US9142781B2
  申请人：——

  公开号：US9142781B2

  公开（公告）日：2015-09-22